Initiator Pharma A/S
SSE:INIT.ST
8.08 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 24.136 | 38.912 | 34.146 | 13.304 | 7.362 | 14.291 | 6.969 | 0.167 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 24.136 | 38.912 | 34.146 | 13.304 | 7.362 | 14.291 | 6.969 | 0.167 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.005 | 0.009 | 0.019 | 0.002 | 0.004 | 2.913 | 2.117 | 0.231 |
Total Current Assets
| 29.769 | 48.328 | 53.701 | 15.592 | 11.401 | 17.204 | 9.086 | 0.398 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0.004 | 0.068 | 0.134 | 0.064 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0.011 | 0.034 | 0.056 | 0.078 | 0.101 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0.011 | 0.034 | 0.056 | 0.078 | 0.101 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.017 | 0.017 | 0 | 0 | -0.001 | 0 | 0 | 0 |
Total Non-Current Assets
| 0.017 | 0.017 | 0 | 0.011 | 0.037 | 0.124 | 0.212 | 0.165 |
Total Assets
| 29.786 | 48.345 | 53.701 | 15.603 | 11.438 | 17.328 | 9.298 | 0.563 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 0.407 | 0.801 | 4.8 | 0.666 | 1.141 | 0.239 | 1.416 | 0 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 2.78 | 0.944 | 0.617 | 0.528 | 0.389 | 0.519 | 1.918 | 0.934 |
Total Current Liabilities
| 3.187 | 1.745 | 5.417 | 1.194 | 1.53 | 0.758 | 3.334 | 0.934 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 15.437 | 12.577 | 13.29 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 15.437 | 12.577 | 13.29 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 18.624 | 14.322 | 18.707 | 1.194 | 1.53 | 0.758 | 3.334 | 0.934 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 5.51 | 5.498 | 4.596 | 2.909 | 2.477 | 2.432 | 0.912 | 0.521 |
Retained Earnings
| 5.652 | 28.525 | 30.398 | 11.5 | 7.431 | 14.138 | 5.052 | -0.892 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
Total Shareholders Equity
| 11.162 | 34.023 | 34.994 | 14.409 | 9.908 | 16.57 | 5.964 | -0.371 |
Total Equity
| 11.162 | 34.023 | 34.994 | 14.409 | 9.908 | 16.57 | 5.964 | -0.371 |
Total Liabilities & Shareholders Equity
| 29.786 | 48.345 | 53.701 | 15.603 | 11.438 | 17.328 | 9.298 | 0.563 |